Synopsis : Fortis Healthcare reported a strong Q4 FY26 performance with net profit rising 44% year-on-year, supported by higher revenues and sharply lower exceptional losses. The hospital chain also outlined aggressive expansion plans, targeting nearly 1,800 additional beds over the next few years.
Fortis Healthcare delivered a solid performance in the March quarter of FY26 as growth across its hospital and diagnostics businesses helped boost revenue and profitability.
The Delhi-based healthcare major reported a consolidated net profit of ₹271.19 crore during Q4 FY26, marking a 44% increase compared to ₹188.02 crore in the same quarter last year.
A major contributor to the earnings improvement was the sharp decline in exceptional losses. The company’s exceptional losses during the quarter dropped nearly 76% year-on-year to ₹1,249 crore, compared with ₹5,357 crore reported during Q4 FY25.
Revenue from operations also witnessed strong growth, rising 17.8% year-on-year to ₹2,365 crore from ₹2,007 crore in the corresponding quarter last year.
The company stated that the growth was largely driven by robust performance across both its hospital operations and diagnostics segment.
Fortis’ hospital business recorded 19% year-on-year revenue growth during the quarter, supported by higher occupancy, improved patient volumes, and growth in average revenue per occupied bed (ARPOB).
ARPOB increased 2% year-on-year to ₹2.56 crore, while occupied beds rose sharply to 3,339 compared with 2,855 beds during Q4 FY25, reflecting nearly 17% growth.
Occupancy levels remained healthy at 68% during the quarter.
Several key medical specialties also reported strong growth momentum. Renal sciences revenue increased 22% year-on-year, while orthopaedics witnessed 21% growth, highlighting improving demand across critical healthcare segments.
The diagnostics business also maintained steady momentum during the quarter. Revenue from diagnostics operations rose 11% year-on-year to ₹387 crore, supported by increased demand from the preventive healthcare portfolio.
Management indicated that preventive healthcare and diagnostics remain important long-term growth drivers for the company as awareness around regular health screening continues increasing.
Alongside operational growth, Fortis Healthcare also outlined its future expansion strategy.
The company said it will continue focusing on brownfield expansion opportunities while also actively evaluating inorganic growth opportunities within key geographic clusters.
During FY26, the company added nearly 500 beds to its network through acquisitions and long-term lease arrangements, including:
- People Tree Hospital
- Shrimann Hospital
- Greater Noida Hospital through a long-term lease arrangement
Fortis Healthcare now operates 6,152 beds across its network as of March 31, 2026.
The company also revealed plans to add another 1,800 beds between FY27 and FY30, excluding any future inorganic acquisitions, signalling continued confidence in long-term healthcare demand in India.
Analysts believe Fortis Healthcare continues benefiting from rising healthcare spending, expansion in high-margin specialties, and increasing demand for organised hospital and diagnostics services across urban markets.
However, investors are expected to closely monitor execution of the company’s expansion strategy, occupancy growth, and operating margin trends over the coming quarters.
Following the earnings announcement, Fortis Healthcare shares closed 0.68% lower at ₹960.45 on the BSE.
Disclaimer : This article is for informational and educational purposes only and should not be considered investment advice. Investors should consult certified financial advisors before making investment decisions.
.jpg)
